Raab & Moskowitz Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,364	Closed	-$164K	–	304
2019 Q4	$164K	Buy	+1,364	New	+$152K	0.06%	169
2018 Q4	–	Sell	-2,417	Closed	-$294K	–	311
2018 Q3	$294K	Sell	2,417 -151	-6%	-$17.8K	0.12%	134
2018 Q2	$282K	Sell	2,568 -84	-3%	-$8.98K	0.13%	131
2018 Q1	$283K	Sell	2,652 -201	-7%	-$22.3K	0.14%	126
2017 Q4	$304K	Sell	2,853 -300	-10%	-$32.1K	0.15%	121
2017 Q3	$330K	Sell	3,153 -201	-6%	-$21.5K	0.16%	117
2017 Q2	$340K	Buy	+3,354	New	+$330K	0.17%	118
2015 Q1	–	Sell	-45	Closed	-$5K	–	231
2014 Q4	$5K	Buy	+45	New	+$4.37K	﹤0.01%	400

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Raab & Moskowitz Asset Management's IBB Position: Q1 2020 in Review

Raab & Moskowitz Asset Management sold out of iShares Biotechnology ETF (IBB) in Q1 2020, closing a stake of 1,364 shares — an estimated $164K sold.

Raab & Moskowitz Asset Management first reported a position in IBB in Q4 2014 and held it in 8 quarters. The position peaked at $340K in Q2 2017. 668 funds tracked by Wall St. Rank hold IBB as of Q1 2020.

Raab & Moskowitz Asset Management reported no remaining iShares Biotechnology ETF position as of Q1 2020 after selling out during the quarter.
Raab & Moskowitz Asset Management sold 1,364 iShares Biotechnology ETF shares in Q1 2020, an estimated $164K.
Raab & Moskowitz Asset Management first reported a position in iShares Biotechnology ETF in Q4 2014 and held it in 8 quarters.
Raab & Moskowitz Asset Management's iShares Biotechnology ETF position peaked at $340K in Q2 2017.
668 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2020.

Based on Raab & Moskowitz Asset Management's 13F filing for Q1 2020, filed 14 May 2020.